Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gore

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Ecancermedicalscience|January 26, 2012
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an updateP Fenaux, G J Mufti, E Hellström-Lindberg, et al.
Haematologica|December 24, 2013
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasmsJoshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
American Journal of Hematology|June 2, 2005
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemiaSteven D Gore, B Douglas Smith, Ivana Gojo, et al.
Leukemia|June 11, 2010
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemiasK W Pratz, E Cho, M J Levis, et al.
Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.
Plos One|September 14, 2017
Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based studyAmer M Zeidan, Jessica B Long, Rong Wang, et al.
Blood|December 21, 2006
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemiasIvana Gojo, Anchalee Jiemjit, Jane B Trepel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based reviewDenise M Oliansky, Joseph H Antin, John M Bennett, et al.
Leukemia & Lymphoma|April 19, 2018
Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey<sup>.</sup>Maximilian Stahl, Alexander Pine, Jeanne E Hendrickson, et al.
Oncotarget|November 16, 2017
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapyThomas Prebet, Thomas Cluzeau, Sophie Park, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Ecancermedicalscience|January 26, 2012
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an updateP Fenaux, G J Mufti, E Hellström-Lindberg, et al.
Haematologica|December 24, 2013
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasmsJoshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
American Journal of Hematology|June 2, 2005
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemiaSteven D Gore, B Douglas Smith, Ivana Gojo, et al.
Leukemia|June 11, 2010
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemiasK W Pratz, E Cho, M J Levis, et al.
Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.
Plos One|September 14, 2017
Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based studyAmer M Zeidan, Jessica B Long, Rong Wang, et al.
Blood|December 21, 2006
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemiasIvana Gojo, Anchalee Jiemjit, Jane B Trepel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based reviewDenise M Oliansky, Joseph H Antin, John M Bennett, et al.
Leukemia & Lymphoma|April 19, 2018
Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey<sup>.</sup>Maximilian Stahl, Alexander Pine, Jeanne E Hendrickson, et al.
Oncotarget|November 16, 2017
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapyThomas Prebet, Thomas Cluzeau, Sophie Park, et al.
Pageof 31